TRiCares gains FDA IDE to initiate tricuspid regurgitation treatment pivotal trial
TRiCares has been granted an investigational device exemption (IDE) by the US Food and Drug Administration (FDA) to initiate a…
TRiCares has been granted an investigational device exemption (IDE) by the US Food and Drug Administration (FDA) to initiate a…
Boston Scientific has shared a duo of positive data readouts from two separate trials evaluating its Watchman FLX left atrial appendage…
Sujay Jadhav, CEO of Verana Health highlights how real-time real-world data dashboards are transforming the way life sciences organisations understand…
The clinical trial supply chain comprises of many stakeholders, including the originating pharma company or biotech, vendors, logistics companies, contract…
Pharmaceutical companies increasingly require more scalability and precision in managing their clinical supply chain. Such demands necessitate stronger, more impactful…
Existing clinical trial supply models are facing a number of challenges - increased market competition, growing trial complexity, a significant…
Existing clinical trial supply models are faced with a number of challenges. Increased market competition, growing clinical trial complexity, a…
As we mark Rare Disease Day 2026, it is worth reflecting on the developments in digitalisation, artificial intelligence (AI), and…
Clinical development has fundamentally changed, yet many supply chains have not. Nowadays making strategic adaptions to ensure secure patient access,…
With the recent conclusion of PharmaPack 2026, this month’s magazine is focused on the key messaging that emanated from the event. With…